| MEDI | Thursday, August 23, 2007 | ||
9:00 AM-12:00 PM BCEC -- 210A, Oral | |||
Antiarrhythmic Agents | |||
| Organizer: | John A. Butera | ||
| 9:00 AM | 447 | Current therapy and innovative targets for treatment of cardiac arrhythmias James K. Hennan | |
| 9:30 AM | 448 | Class III antiarrhythmic agents: Delayed cardiac repolarization by selective blockade of IKr, IKs or IKur Harold Selnick | |
| 10:00 AM | 449 | Design and synthesis of orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation B. Wesley Trotter | |
| 10:30 AM | 450 | Discovery of potent gap-junction modifiers as novel antiarrhythmic agents: From stable hexa-peptides to orally available small molecules John A. Butera, Bjarne Due Larsen, Edward Kerns, Li Di, James K. Hennan, Robert Swillo, Gwen Morgan, Christine Huselton, Ray J Unwalla, Jørgen Petersen | |
| 11:00 AM | 451 | A1 Adenosine receptor agonists as ventricular rate control agents during atrial fibrillation Jeff Zablocki, Elfatih Elzein, Rao Kalla, Xiaofen Li, Thao Perry, Tim Marquart, Hugh Genin, Mark Micklatcher, John Shryock, Lin Wu, Yuan Li, Yuzhi Wu, Dewan Zeng, Arvinder Dhalla, Irene Lepist, Brian Stafford, Kwan Leung | |
| 11:30 AM | 452 | Discovery of nicotinamides and related derivatives as potent and selective NCX reverse mode inhibitors Akio Kakefuda, Takahiro Kuramochi, Hiroyoshi Yamada, Ippei Sato, Issei Tsukamoto, Taku Taguchi, Shuichi Sakamoto | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 234th ACS National Meeting, Boston, MA, August 19-23, 2007